Samsung panels to dominate display of new iPhone14 series

Internal info suggests that Apple procured 82% of panel from Samsung, 12% from the Korean company LG, and 6% from Chinese firm BOE for its upcoming versions of iPhone

Apple hiring in India

Washington: The new series of iPhones are likely to have display from Samsung, LG and Chinese firm BOE, as reported by Ross Young from DSCC (Display Supply Chain Consultants) states.

Internal info suggests that Apple procured 82% of panel from Samsung, 12% from the Korean company LG, and 6% from Chinese firm BOE for its upcoming versions of iPhone.

The reports from GSM Arena revealed that the early versions of iPhone 14 pro max units would have only Samsung panels. The LG, which is grappling with some tech issues to meet the demand will start sending the consignments to Apple as early as September.

Though the Chinese firm BOE is capable of manufacturing good volumes of screens, the Apple has limited its purchases to iPhone 14 series and the display panel supplied by it is unlikely to be used in the Pro versions.

Also Read: Samsung logs over 50K prebooking for new foldable mobiles in India

Samsung has supplied display panel to Apple for its iPhone 13 series as well. Officials said that Samsung has about 83% share in screens of iPhone 13 series. Detail info from Young suggests that shipment from display factories to assembly plants were 1.8 million in June 5.35 million in July, over 10 million in August and over 16.5 million in September.

Reports have it that Apple is preparing to have at least 34 million units for sale in the first three months after launch of iPhone 14 series. Apple has slated to launch the all four versions of the new series of iPhones—iPhone 14, iPhone 14 Max, iPhone 14 Pro and iPhone 14 Pro Max—in Cupertino on September 7.

Tech analysts noted that it would be interesting to see how the new A16 chipset is going to enhance functionality features of the iPhone in its Pro versions and the new smart watches.

Previous articleGST collection jumps to ₹1.43 lakh cr in Aug
Next articleCervavac, India’s own vaccine against Cervical cancer launched

LEAVE A REPLY

Please enter your comment!
Please enter your name here